Skip to main content
OpenTrials

Clinical trial condition

C3 Glomerulopathy

Explore clinical trials studying C3 Glomerulopathy. Study availability and eligibility vary by location and protocol.

16 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

C3 Glomerulopathy trial results

Recruiting

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

NCT06209736

Conditions
C3 Glomerulopathy, Idiopathic Immune Complex-Mediated Glomerulonephritis
Locations
  • Omeros Investigational Site Kaunas, Lithuania
  • Omeros Investigational Site Vilnius, Lithuania
  • Omeros Investigational Site Auckland, New Zealand
  • Omeros Investigational Site Lodz, Poland
View Trial Details
Not yet recruiting

A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases

NCT06786338

Conditions
Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +11 more
Locations
  • Peking University First Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • The Third Xiangya Hospital of Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
View Trial Details
Active, not recruiting

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05809531

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Academic Medical Research Institute (01034) Los Angeles, California, United States
  • Children's Hospital Colorado (01037) Aurora, Colorado, United States
  • University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States
  • Emory Investigational Drug Service (01021) Atlanta, Georgia, United States
View all 47 locations
View Trial Details

Related conditions